Last reviewed · How we verify

NCT07177183: SECRET-VENT

Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning Failure

Recruiting now NA Last updated 5 February 2026
What this trial tests

NA trial testing Dietary supplement creatine in Prolonged Mechanical Ventilation in 492 participants. Currently enrolling.

Timeline
2 February 2026
Primary endpoint
31 December 2027
2 February 2028

Quick facts

Lead sponsorUniversity Hospital Ostrava
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment492
Start date2 February 2026
Primary completion31 December 2027
Estimated completion2 February 2028
Sites2 locations across Czechia

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital Ostrava

Who can join

18 and older, any sex, with Prolonged Mechanical Ventilation or Critical Illness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of the study is to determine whether a subnormal serum creatinine value upon admission to the Post-ICU Care Unit predicts the need for prolonged ventilatory support. A parallel objective of the study is to determine whether exogenous in-take of the dietary supplement creatine in patients with subnormal serum creatinine value is associated with a shortened duration of ventilatory support and improved patients outcome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Prolonged Mechanical Ventilation

Currently open trials in the same condition.

Other University Hospital Ostrava trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07177183.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing